Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

View source ↗

Summary

A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatomyositis
• Lupus Nephritis
• Multiple Sclerosis
• Myasthenia Gravis
• Rheumatoid Arthritis
• Stiff-person Syndrome
• Systemic Sclerosis

Drugs mentioned

• KYV-101

Snippet

Sponsor: Kyverna Therapeutics | Conditions: Refractory Lupus Nephritis, Myasthaenia Gravis | Status: RECRUITING